Detalles de la búsqueda
1.
NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.
J Allergy Clin Immunol
; 143(1): 126-134.e5, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29928924
2.
A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis.
Allergy Asthma Proc
; 40(1): 48-56, 2019 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30582496
3.
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
Headache
; 55(1): 88-100, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25355310
4.
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Headache
; 55(5): 621-35, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25941016
5.
EDS-FLU performs differently than other nasal corticosteroids.
J Allergy Clin Immunol
; 144(1): 349, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31076091
6.
Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2).
J Allergy Clin Immunol Pract
; 12(4): 1049-1061, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244014
7.
Breath powered nasal delivery: a new route to rapid headache relief.
Headache
; 53 Suppl 2: 72-84, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24024605
8.
Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder.
Headache
; 53(8): 1323-33, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23992438
9.
The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain.
Anesth Analg
; 112(3): 693-702, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21304148
10.
A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic pain.
Pain Med
; 11(9): 1313-27, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20807345
11.
Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough pain.
Pain Pract
; 10(4): 287-93, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20230447
12.
Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts.
Ther Deliv
; 11(8): 485-495, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727298
13.
A Race Against Time-Changing the Natural History of CRIM Negative Infantile Pompe Disease.
Front Immunol
; 11: 1929, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33013846
14.
A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol.
Clin Ther
; 41(11): 2343-2356, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732149
15.
NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
Am J Rhinol Allergy
; 33(1): 69-82, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477309
16.
EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis.
Int Forum Allergy Rhinol
; 2018 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29856520
17.
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Clin Ther
; 29(4): 588-601, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17617282
18.
Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
J Support Oncol
; 5(7): 327-34, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17708123
19.
EDS-FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps.
Int Forum Allergy Rhinol
; 12(6): 893-895, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348302
20.
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
Clin J Pain
; 22(9): 805-11, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17057563